about
Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trialDifferences in PGE2 production between primary human monocytes and differentiated macrophages: role of IL-1β and TRIF/IRF3.Distribution of mitochondrial NADH fluorescence lifetimes: steady-state kinetics of matrix NADH interactions.Use of (32)P to study dynamics of the mitochondrial phosphoproteomeClinical Trials in a DishCommon Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.Acute effects of nonexcitatory electrical stimulation during systole in isolated cardiac myocytes and perfused heart.Fluctuation analysis of mitochondrial NADH fluorescence signals in confocal and two-photon microscopy images of living cardiac myocytes.Comparative analysis of media effects on human induced pluripotent stem cell-derived cardiomyocytes in proarrhythmia risk assessment.Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias.Comprehensive In Vitro Proarrhythmia Assay (CiPA) Update from a Cardiac Safety Research Consortium / Health and Environmental Sciences Institute / FDA MeetingInternational Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential AssessmentClinical Trial in a Dish: Personalized Stem Cell-Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT-Prolonging DrugsAssessment of Proarrhythmic Potential of Drugs in Optogenetically Paced Induced Pluripotent Stem Cell-Derived CardiomyocytesEvaluating the use of microelectrode array technology and cell-based neuronal culture models for proconvulsant risk assessment: progress from the HESI NeuTox consortium
P50
Q33647242-EE1E5E73-7286-4AA8-9A81-B069B7980DEBQ33679721-15B96F2C-F29B-4D83-B4FE-EE58452B9CAFQ33679721-571E0C02-5335-4596-8369-95F34BC506EBQ33985030-2B691158-C286-4162-B468-09B8F161FB16Q35225791-B7FB71E4-514A-40A5-AEB9-9A798E7CDD3FQ37737063-2683CEC9-BDF6-468C-B29E-5523B4DD3A61Q38380613-8B44D03A-E2F7-4914-8A4A-C323EA5B9EAFQ41877489-B7B76882-D995-44F8-AD9F-6DFD47BF3FA2Q47316608-55F37A24-675E-428F-8681-51B2EFEFBA39Q47332440-EB11F4F2-5BC7-4439-82CA-4383F77D52FAQ51146786-C9DB7941-DA1D-46E8-932B-8EFBCD3D5023Q56975670-8A5B76CA-1586-43EC-8D0E-8D17AE46DF5EQ58696730-9C26A0D5-9DE3-4335-81F9-378C5C6C0319Q92066831-3B23C398-474D-4131-8F35-B8F8F410A695Q92625286-FE9C00F6-45B9-4BFF-A0DC-4CDD3D98D539Q92807964-74A6D625-2EC3-465E-BA0A-F2B96A53B47D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ksenia Blinova
@ast
Ksenia Blinova
@en
Ksenia Blinova
@es
Ksenia Blinova
@nl
type
label
Ksenia Blinova
@ast
Ksenia Blinova
@en
Ksenia Blinova
@es
Ksenia Blinova
@nl
prefLabel
Ksenia Blinova
@ast
Ksenia Blinova
@en
Ksenia Blinova
@es
Ksenia Blinova
@nl
P106
P1153
57096253500
P31
P496
0000-0003-1123-3152